HM
SUPN icon

Harvest Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Harvest Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Sell
7,100
-3,900
-35% -$199K 0.18% 46
2025
Q4 		$547K Buy
11,000
+1,000
+10% +$48.6K 0.18% 48
2025
Q3 		$478K Buy
+10,000
New +$403K 0.21% 48

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Management's SUPN Position: Q1 2026 in Review

Harvest Management reduced its Supernus Pharmaceuticals (SUPN) stake by 35% in Q1 2026, selling an estimated $199K and leaving 7,100 shares worth $367K. The position accounts for 0.18% of the portfolio, ranked #46.

Harvest Management first reported a position in SUPN in Q3 2025 and has held it in 3 quarters since. The position peaked at $547K in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Harvest Management held 7,100 shares of Supernus Pharmaceuticals worth $367K as of Q1 2026.
  • Harvest Management sold 3,900 Supernus Pharmaceuticals shares in Q1 2026, an estimated $199K.
  • Supernus Pharmaceuticals made up 0.18% of Harvest Management's portfolio in Q1 2026, its #46 holding.
  • Harvest Management first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Harvest Management's Supernus Pharmaceuticals position peaked at $547K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Harvest Management's 13F filing for Q1 2026, filed 15 May 2026.